Mathematical models and health economic aspects of microbicides
- PMID: 19373026
- DOI: 10.1097/COH.0b013e328305b959
Mathematical models and health economic aspects of microbicides
Abstract
Purpose of review: This paper reviews the literature of mathematical modeling and health economics of microbicides. These analyses can aid decision-making for microbicide development, usage in a population, and allocation of limited resources to maximize HIV prevention.
Recent findings: Mathematical models initially forecasted the large positive impact of moderately effective microbicides. These models also predicted that condom replacement would not be a significant concern in most populations. Modeling studies have also considered biophysical interactions of HIV with microbicide gels, the impact of rectal microbicides among gay men, and behavioral and epidemiological factors that are likely to be important. Recent innovative modeling has shown that second-generation microbicides, containing antiretroviral drugs, could lead to high rates of drug resistance when used in public health interventions even if resistance is not detected during clinical trials. Limited analysis of microbicide cost-effectiveness has occurred to date. We provide an analysis of microbicide cost-effectiveness and find that it is highly dependent on HIV incidence in the population and microbicide dosing frequency.
Summary: Modeling has been influential in forecasting the potential public health benefit of microbicides and in warning of possible risks. Models of microbicide cost-effectiveness provide important perspectives in guiding access to future microbicides.
Similar articles
-
Microbicides for the prevention of HIV infection in women: an overview of recent trials.Curr Opin HIV AIDS. 2006 Nov;1(6):514-9. doi: 10.1097/01.COH.0000247386.62743.b4. Curr Opin HIV AIDS. 2006. PMID: 19372855
-
Microbicide acceptability research: current approaches and future directions.Soc Sci Med. 2005 Jan;60(2):319-30. doi: 10.1016/j.socscimed.2004.05.011. Soc Sci Med. 2005. PMID: 15522488 Review.
-
Microbicide delivery: formulation technologies and strategies.Curr Opin HIV AIDS. 2008 Sep;3(5):558-66. doi: 10.1097/COH.0b013e328305b96e. Curr Opin HIV AIDS. 2008. PMID: 19373022
-
Microbicides: chemistry, structure, and strategy.Curr Opin HIV AIDS. 2008 Sep;3(5):548-53. doi: 10.1097/COH.0b013e32830ab9dd. Curr Opin HIV AIDS. 2008. PMID: 19373020
-
Microbicides for HIV prevention: reality or hope?Curr Opin Infect Dis. 2010 Feb;23(1):26-31. doi: 10.1097/QCO.0b013e328334fe70. Curr Opin Infect Dis. 2010. PMID: 19935418 Review.
Cited by
-
Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.Am J Law Med. 2012;38(4):607-66. doi: 10.1177/009885881203800402. Am J Law Med. 2012. PMID: 23356098 Free PMC article.
-
Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.BMC Res Notes. 2012 Nov 1;5:613. doi: 10.1186/1756-0500-5-613. BMC Res Notes. 2012. PMID: 23116431 Free PMC article.
-
The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention.Sex Transm Infect. 2011 Dec;87(7):646-53. doi: 10.1136/sextrans-2011-050184. Sex Transm Infect. 2011. PMID: 22110117 Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials